Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP805735.RAhw9jiQ7Zz8ahrI1G9RoBGI4UFn2YHtEF46d0bH6Y2ng130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP805735.RAhw9jiQ7Zz8ahrI1G9RoBGI4UFn2YHtEF46d0bH6Y2ng130_assertion type Assertion NP805735.RAhw9jiQ7Zz8ahrI1G9RoBGI4UFn2YHtEF46d0bH6Y2ng130_head.
- NP805735.RAhw9jiQ7Zz8ahrI1G9RoBGI4UFn2YHtEF46d0bH6Y2ng130_assertion description "[We found that AAPCs genetically modified to express CAP1, the agonist peptide CAP1-6D, or the whole CEA protein were not able to activate CAP1-specific CTLs from HLA-A*0201+ healthy donors or patients with colorectal carcinoma, even after multiple stimulations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP805735.RAhw9jiQ7Zz8ahrI1G9RoBGI4UFn2YHtEF46d0bH6Y2ng130_provenance.
- NP805735.RAhw9jiQ7Zz8ahrI1G9RoBGI4UFn2YHtEF46d0bH6Y2ng130_assertion evidence source_evidence_literature NP805735.RAhw9jiQ7Zz8ahrI1G9RoBGI4UFn2YHtEF46d0bH6Y2ng130_provenance.
- NP805735.RAhw9jiQ7Zz8ahrI1G9RoBGI4UFn2YHtEF46d0bH6Y2ng130_assertion SIO_000772 20386466 NP805735.RAhw9jiQ7Zz8ahrI1G9RoBGI4UFn2YHtEF46d0bH6Y2ng130_provenance.
- NP805735.RAhw9jiQ7Zz8ahrI1G9RoBGI4UFn2YHtEF46d0bH6Y2ng130_assertion wasDerivedFrom befree-2016 NP805735.RAhw9jiQ7Zz8ahrI1G9RoBGI4UFn2YHtEF46d0bH6Y2ng130_provenance.
- NP805735.RAhw9jiQ7Zz8ahrI1G9RoBGI4UFn2YHtEF46d0bH6Y2ng130_assertion wasGeneratedBy ECO_0000203 NP805735.RAhw9jiQ7Zz8ahrI1G9RoBGI4UFn2YHtEF46d0bH6Y2ng130_provenance.